How I treat chronic graft-versus-host disease.
暂无分享,去创建一个
[1] S. Piantadosi,et al. Development of a prognostic model for grading chronic graft-versus-host disease. , 2001, Blood.
[2] E. Farmer,et al. Etretinate therapy for refractory sclerodermatous chronic graft-versus-host disease. , 1999, Blood.
[3] H. Hönigsmann,et al. Successful use of extracorporeal photochemotherapy in the treatment of severe acute and chronic graft-versus-host disease. , 1998, Blood.
[4] J. Ferrara,et al. Graft-versus-host disease: the influence of type 1 and type 2 T cell cytokines. , 1998, Transfusion medicine reviews.
[5] B. Bierer,et al. Treatment of chronic graft-versus-host disease with clofazimine. , 1997, Blood.
[6] E. Farmer,et al. Treatment of chronic graft-versus-host disease with ultraviolet irradiation and psoralen (PUVA). , 1996, Bone marrow transplantation.
[7] A. Mazumder,et al. The effect of hydroxychloroquine on alloreactivity and its potential use for graft-versus-host disease. , 1996, Bone marrow transplantation.
[8] W. Krenger,et al. Graft-versus-host disease and the Th1/Th2 paradigm , 1996, Immunologic research.
[9] Charles E. Kahn,et al. graft-vs.-host disease , 1995 .
[10] C. Sidman,et al. Differential cytokine expression in acute and chronic murine graft‐versus‐host‐disease , 1993, European journal of immunology.
[11] A. Hess,et al. Cyclosporine-induced syngeneic graft-versus-host disease: recognition of self MHC class II antigens in vivo. , 1993, Transplantation proceedings.
[12] P. De Baetselier,et al. Preferential activation of Th2 cells in chronic graft-versus-host reaction. , 1993, Journal of immunology.
[13] C. Shanley,et al. Total lymphoid irradiation for treatment of drug resistant chronic GVHD. , 1993, Bone marrow transplantation.
[14] D. Jabs,et al. Thalidomide for the treatment of chronic graft-versus-host disease. , 1992, The New England journal of medicine.
[15] T. Starzl,et al. FK 506 rescue in chronic graft-versus-host-disease after bone marrow transplantation. , 1991, Transplantation proceedings.
[16] K. Sullivan,et al. Chronic graft-versus-host disease and other late complications of bone marrow transplantation. , 1991, Seminars in hematology.
[17] H. Deeg,et al. Transfusions shortly before HLA-matched marrow transplantation for leukemia are associated with a decrease in chronic graft-versus-host disease. , 1991, Bone marrow transplantation.
[18] T. Lamparelli,et al. Cyclosporin A and chronic graft versus host disease. , 1990, Bone marrow transplantation.
[19] M. Pepe,et al. Cytomegalovirus infection after marrow transplantation for aplastic anemia. , 1990, Bone marrow transplantation.
[20] C. Perreault,et al. Minor histocompatibility antigens. , 1990, Blood.
[21] K. Sullivan,et al. Value of day 100 screening studies for predicting the development of chronic graft-versus-host disease after allogeneic bone marrow transplantation. , 1990, Blood.
[22] A. Rimm,et al. Risk factors for chronic graft-versus-host disease after HLA-identical sibling bone marrow transplantation. , 1990, Blood.
[23] O. Ringdén,et al. A European multicenter study of chronic graft-versus-host disease. The role of cytomegalovirus serology in recipients and donors--acute graft-versus-host disease, and splenectomy. , 1990, Transplantation.
[24] P. Ljungman,et al. LONG‐TERM CYCLOSPORIN THERAPY MAY DECREASE THE RISK OF CHRONIC GRAFT‐VERSUS‐HOST DISEASE , 1990, British journal of haematology.
[25] J. Pierga,et al. Low-dose (one gray) total-lymphoid irradiation for extensive, drug-resistant chronic graft-versus-host disease. , 1990, Transplantation.
[26] S. Piantadosi,et al. Predictors of death from chronic graft-versus-host disease after bone marrow transplantation. , 1989, Blood.
[27] A. Rimm,et al. Consensus among bone marrow transplanters for diagnosis, grading and treatment of chronic graft-versus-host disease. Committee of the International Bone Marrow Transplant Registry. , 1989, Bone marrow transplantation.
[28] Jean E. Sanders,et al. Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-v-host disease: prognostic influence of prolonged thrombocytopenia after allogeneic marrow transplantation. , 1988, Blood.
[29] H. Deeg,et al. Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-v-host disease. , 1988, Blood.
[30] E. Elonen,et al. Low incidence of severe acute and chronic graft-versus-host disease as a result of prolonged cyclosporine prophylaxis and early aggressive treatment with corticosteroids. , 1988, Transplantation proceedings.
[31] K. Atkinson,et al. PUVA therapy for drug-resistant graft-versus-host disease. , 1986, Bone marrow transplantation.
[32] K. Sullivan,et al. Second marrow infusion for poor graft function after allogeneic marrow transplantation. , 1986, Bone marrow transplantation.
[33] E. Farmer,et al. Methoxsalen and ultraviolet A radiation in treatment of chronic cutaneous graft-versus-host reaction. , 1985, Journal of the American Academy of Dermatology.
[34] H. Deeg,et al. CYCLOSPORIN A AND METHOTREXATE IN CANINE MARROW TRANSPLANTATION: ENGRAFTMENT, GRAFT‐VERSUS-HOST DISEASE, AND INDUCTION OF TOLERANCE , 1982, Transplantation.
[35] K. Sullivan,et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. , 1980, The American journal of medicine.